Chemical Structure (Onpattro 01)
Onpattro Injection, Lipid Complex
Product Images NDC 71336-1000
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Onpattro (NDC 71336-1000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Alnylam Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Onpattro 02)
Figure 2 (Onpattro 03)
The text is not available.*
Figure 3 (Onpattro 04)
Figure 4 (Onpattro 05)
This is a chart that displays the Percent of patients reported to have improved (Better) or worsened (Worse) over a treatment period. The chart shows data for two groups: those who were administered a placebo (N=77) and those who received ONPATTRO(N=148). It also shows the Norfolk QoL-DN change from baseline at Month 18.*
Principal Display Panel (2 mg/mL Vial Carton)
ONPATTRO is a registered trademark for a lipid complex injection that contains patisiran and is used for intravenous infusion only. It comes in a single-dose vial and should be discarded after use. It contains a list of ingredients, including patisiran sodium, cholesterol, and various sodium and potassium phosphates. The injection should be refrigerated at 2°C to 8°C and should not be frozen or shaken. Consult the package insert for dosage and administration information. The medication is manufactured by Ajinomoto Althea, Inc. in San Diego and is manufactured for Alnylam Pharmaceuticals, Inc. located in Cambridge, MA. Rx only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
